HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

Rhea-AI Summary

HeartBeam (NASDAQ: BEAT), a cardiac care medical technology company, has announced its participation in two major conferences in Dana Point, California during March 2025. CEO Robert Eno and CFO Timothy Cruickshank will attend:

• The 37th Annual Roth Conference at The Laguna Cliffs Marriott Resort & Spa from March 16-18, 2025
• The LSI USA '25 Conference at the Waldorf Astoria, Monarch Beach from March 17-21, 2025

Investors interested in one-on-one meetings with HeartBeam management can arrange appointments through their conference representatives or by contacting BEAT@mzgroup.us.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that CEO Robert Eno and CFO Timothy Cruickshank will be participating in the following upcoming conferences in Dana Point, CA.

• 37th Annual Roth Conference being held at The Laguna Cliffs Marriott Resort & Spa, March 16-18, 2025
• LSI USA ’25 Conference being held at the Waldorf Astoria, Monarch Beach, March 17-21, 2025

To schedule a one-on-one meeting with HeartBeam management, please contact your conference representative or email your request to BEAT@mzgroup.us or call Chris Tyson at (949) 491-8235.

About HeartBeam, Inc.

HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first ever cable-free synthesized 12-lead ECG capable of capturing the heart’s electrical signals from three distinct directions. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health management. The Company holds 13 US and 4 international issued patents related to technology enablement. For additional information, visit HeartBeam.com.

Forward-Looking Statements

All statements in this release that are not based on historical fact are "forward-looking statements." While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our Forms 10-K, 10-Q and other reports filed with the SEC and available at www.sec.gov. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250306016350/en/

Investor Relations Contact:

Chris Tyson

Executive Vice President

MZ North America

Direct: 949-491-8235

BEAT@mzgroup.us

www.mzgroup.us

Media Contact:

media@heartbeam.com

Source: HeartBeam, Inc.

FAQ

When and where will HeartBeam (BEAT) participate in conferences in March 2025?

HeartBeam will participate in two conferences in Dana Point, CA: the 37th Annual Roth Conference (March 16-18) and LSI USA '25 Conference (March 17-21).

Which HeartBeam executives will attend the March 2025 conferences?

CEO Robert Eno and CFO Timothy Cruickshank will represent HeartBeam at both conferences.

How can investors schedule meetings with HeartBeam (BEAT) management at the conferences?

Investors can schedule meetings through conference representatives or by emailing BEAT@mzgroup.us.

What is the duration of HeartBeam's participation in the LSI USA '25 Conference?

HeartBeam will participate in the LSI USA '25 Conference for five days, from March 17-21, 2025.